Drugs / Standard Treatment
Standard Treatment
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04691700 Comparator | Jan 2021 → Dec 2027 expected | heart failure | Takeshi Morimoto | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard Treatment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04691700 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Goreisan, a traditional Japanese herbal medicine” PMID 36841318 ↗ Feb 2023 |